Lactate dehydrogenase‐to‐albumin ratio: A superior inflammatory marker for predicting contrast‐associated acute kidney injury after percutaneous coronary intervention
Key Points:
- LAR is a strong predictor of CA-AKI, reflecting both tissue damage and inflammatory status in PCI patients.
- Higher LAR levels are associated with an increased risk of kidney injury following contrast exposure.
- The study suggests LAR as a valuable tool for improving early detection and preventive strategies in high-risk patients.
Description
This study explores the lactate dehydrogenase-to-albumin ratio (LAR) as a novel and superior inflammatory marker for predicting contrast-associated acute kidney injury (CA-AKI) after percutaneous coronary intervention (PCI). By comparing LAR with traditional biomarkers, it highlights its potential role in early risk stratification and patient management.
Be the first to review “Lactate dehydrogenase‐to‐albumin ratio: A superior inflammatory marker for predicting contrast‐associated acute kidney injury after percutaneous coronary intervention”
Reviews
There are no reviews yet.